Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05267626
Title Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Ra Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Aulos Bioscience, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | AUS

Facility Status City State Zip Country Details
START Midwest RECRUITING Grand Rapids Michigan 49503-2563 United States Details
Carolina Biooncology Institute RECRUITING Huntersville North Carolina 28078 United States Details
Tennessee Oncology RECRUITING Nashville Tennessee 37203-1619 United States Details
MD Anderson Cancer Center RECRUITING Houston Texas 77030-4000 United States Details
START South Texas Accelerated Research Therapeutics RECRUITING San Antonio Texas 78229 United States Details
University of Utah - Huntsman Cancer Institute RECRUITING Salt Lake City Utah 84112 United States Details
Southside Cancer Care Centre RECRUITING Miranda New South Wales 2228 Australia Details
Southern Oncology Clinical Research Unit RECRUITING Bedford Park South Australia 5042 Australia Details
Monash Health RECRUITING Clayton Victoria 3168 Australia Details
Peninsula & South Eastern Haematology and Oncology Group RECRUITING Frankston Victoria 3199 Australia Details
Austin Health RECRUITING Heidelberg Victoria 3084 Australia Details
The Alfred Hospital RECRUITING Melbourne Victoria 3004 Australia Details
Sunshine Hospital RECRUITING Saint Albans Victoria 3021 Australia Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field